Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;79(11-12):1727–1735. doi: 10.1038/sj.bjc.6690275

Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study

K H Lee 1, J S Lee 1, J H Lee 1, S W Kim 1, C Suh 1, W K Kim 1, S-H Kim 1, Y I Min 1, B S Kim 2, K C Park 2, M S Lee 3, H S Sun 4
PMCID: PMC2362816  PMID: 10206284

Abstract

The role of DNA flow cytometry in the prediction of prognosis for patients with stomach cancer remains to be defined. Thus we studied prospectively the role of DNA flow cytometry as a prognosis indicator in stomach cancer patients in a high-incidence area. Between November 1990 and December 1992, primary stomach cancer tissues were obtained from the surgical specimens from 217 patients (148 male, 69 female). DNA flow cytometric analyses of DNA ploidy and S-phase fraction were performed and the results were correlated with patient survival. The median age of the patients was 55 years (range 24–78). Aneuploid cell population was found in 114 of 217 samples (53%). Tumour S-phase fraction was obtained in 96 of 103 diploid tumours (93%) and 61 of 114 aneuploid tumours (54%). After median follow-up of 66.1 months, the patients with tumours with an S-phase fraction over 17% had significantly worse survival rates than patients with tumours with S-phase fractions of lower than 8% or 8–17% (45% vs 59% and 63% of patients surviving, P = 0.007). Tumour ploidy status did not correlate with patient survival. Multivariate analyses showed that the TNM stage remained the most important prognostic indicator. The tumour S-phase fraction was also an independent prognostic indicator (relative risk 2.300, 95% CI, 1.252–4.223). Tumour S-phase fraction obtained by DNA flow cytometry is an independent prognostic indicator for the survival of the patients with stomach cancer. © 1999 Cancer Research Campaign

Keywords: stomach cancer, DNA flow cytometry, DNA ploidy, S-phase fraction, prognostic factor

Full Text

The Full Text of this article is available as a PDF (118.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baretton G., Carstensen O., Schardey M., Löhrs U. DNA-ploidy and survival in gastric carcinomas: a flow-cytometric study. Virchows Arch A Pathol Anat Histopathol. 1991;418(4):301–309. doi: 10.1007/BF01600158. [DOI] [PubMed] [Google Scholar]
  2. Bauer K. D., Bagwell C. B., Giaretti W., Melamed M., Zarbo R. J., Witzig T. E., Rabinovitch P. S. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry. 1993;14(5):486–491. doi: 10.1002/cyto.990140506. [DOI] [PubMed] [Google Scholar]
  3. Bronzo R., Heit P., Weissman G., Kahn E., McKinley M. Implications of flow cytometry in malignant conditions of the stomach. Am J Gastroenterol. 1989 Sep;84(9):1065–1068. [PubMed] [Google Scholar]
  4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992 Dec 15;52(24):6735–6740. [PubMed] [Google Scholar]
  5. D'Agnano I., D'Angelo C., Savarese A., Carlini M., Garofalo A., Bottari L., Santoro E., Giannarelli D., Vecchione A., Zupi G. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers. Lab Invest. 1995 Apr;72(4):432–438. [PubMed] [Google Scholar]
  6. Dressler L. G., Bartow S. A. DNA flow cytometry in solid tumors: practical aspects and clinical applications. Semin Diagn Pathol. 1989 Feb;6(1):55–82. [PubMed] [Google Scholar]
  7. Fenoglio-Preiser C. M., Noffsinger A. E., Belli J., Stemmermann G. N. Pathologic and phenotypic features of gastric cancer. Semin Oncol. 1996 Jun;23(3):292–306. [PubMed] [Google Scholar]
  8. Filipe M. I., Rosa J., Sandey A., Imrie P. R., Ormerod M. G., Morris R. W. Is DNA ploidy and proliferative activity of prognostic value in advanced gastric carcinoma? Hum Pathol. 1991 Apr;22(4):373–378. doi: 10.1016/0046-8177(91)90085-4. [DOI] [PubMed] [Google Scholar]
  9. Flyger H. L., Christensen I. J., Thorup J., Håkansson T. U., Nørgaard T. DNA aneuploidy in gastric carcinoma. Flow cytometric data related to survival, location, and histopathologic findings. Scand J Gastroenterol. 1995 Mar;30(3):258–264. doi: 10.3109/00365529509093274. [DOI] [PubMed] [Google Scholar]
  10. Haffty B. G., Toth M., Flynn S., Fischer D., Carter D. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient. J Clin Oncol. 1992 Dec;10(12):1839–1847. doi: 10.1200/JCO.1992.10.12.1839. [DOI] [PubMed] [Google Scholar]
  11. Hedley D. W., Clark G. M., Cornelisse C. J., Killander D., Kute T., Merkel D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference. Cytometry. 1993;14(5):482–485. doi: 10.1002/cyto.990140505. [DOI] [PubMed] [Google Scholar]
  12. Hermans J., Bonenkamp J. J., Boon M. C., Bunt A. M., Ohyama S., Sasako M., Van de Velde C. J. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol. 1993 Aug;11(8):1441–1447. doi: 10.1200/JCO.1993.11.8.1441. [DOI] [PubMed] [Google Scholar]
  13. Ikeguchi M., Ohfuji S., Oka A., Tsujitani S., Maeta M., Kaibara N. Aneuploidy of tumor cells in cases of gastric cancer with esophageal invasion: another indicator of poor prognosis. J Surg Oncol. 1995 Feb;58(2):83–90. doi: 10.1002/jso.2930580203. [DOI] [PubMed] [Google Scholar]
  14. Johnson H., Jr, Belluco C., Masood S., Abou-Azama A. M., Kahn L., Wise L. The value of flow cytometric analysis in patients with gastric cancer. Arch Surg. 1993 Mar;128(3):314–317. doi: 10.1001/archsurg.1993.01420150070013. [DOI] [PubMed] [Google Scholar]
  15. Kakeji Y., Maehara Y., Korenaga D., Tsujitani S., Haraguchi M., Watanabe A., Orita H., Sugimachi K. Prognostic significance of tumor-host interaction in clinical gastric cancer: relationship between DNA ploidy and dendritic cell infiltration. J Surg Oncol. 1993 Apr;52(4):207–212. doi: 10.1002/jso.2930520402. [DOI] [PubMed] [Google Scholar]
  16. Kimura H., Yonemura Y. Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis. Cancer. 1991 May 15;67(10):2588–2593. doi: 10.1002/1097-0142(19910515)67:10<2588::aid-cncr2820671031>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  17. Korenaga D., Haraguchi M., Okamura T., Baba H., Saito A., Sugimachi K. DNA ploidy and tumor invasion in human gastric cancer. Histopathologic differentiation. Arch Surg. 1989 Mar;124(3):314–318. doi: 10.1001/archsurg.1989.01410030064011. [DOI] [PubMed] [Google Scholar]
  18. LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31–49. doi: 10.1111/apm.1965.64.1.31. [DOI] [PubMed] [Google Scholar]
  19. Lee K. H., Lee J. S., Suh C., Ahn M. J., Kim S. W., Doh B. S., Min Y. I., Kim B. S., Park K. C., Lee I. C. DNA flow cytometry of stomach cancer. Prospective correlation with clinicopathologic findings. Cancer. 1993 Sep 15;72(6):1819–1826. doi: 10.1002/1097-0142(19930915)72:6<1819::aid-cncr2820720605>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  20. Look A. T., Douglass E. C., Meyer W. H. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. N Engl J Med. 1988 Jun 16;318(24):1567–1572. doi: 10.1056/NEJM198806163182403. [DOI] [PubMed] [Google Scholar]
  21. Merkel D. E., Dressler L. G., McGuire W. L. Flow cytometry, cellular DNA content, and prognosis in human malignancy. J Clin Oncol. 1987 Oct;5(10):1690–1703. doi: 10.1200/JCO.1987.5.10.1690. [DOI] [PubMed] [Google Scholar]
  22. Nanus D. M., Kelsen D. P., Niedzwiecki D., Chapman D., Brennan M., Cheng E., Melamed M. Flow cytometry as a predictive indicator in patients with operable gastric cancer. J Clin Oncol. 1989 Aug;7(8):1105–1112. doi: 10.1200/JCO.1989.7.8.1105. [DOI] [PubMed] [Google Scholar]
  23. Rugge M., Sonego F., Panozzo M., Baffa R., Rubio J., Jr, Farinati F., Nitti D., Ninfo V., Ming S. C. Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis. Cancer. 1994 Feb 15;73(4):1127–1133. doi: 10.1002/1097-0142(19940215)73:4<1127::aid-cncr2820730402>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  24. Sakusabe M., Kodama M., Sato Y., Kikuchi T., Koyama K. Clinical significance of DNA ploidy pattern in stage III gastric cancer. World J Surg. 1996 Jan;20(1):27–31. doi: 10.1007/s002689900005. [DOI] [PubMed] [Google Scholar]
  25. Sarbia M., Molsberger G., Willers R., Horstmann O., Schroders C., Porschen R., Gabbert H E. The prognostic significance of DNA ploidy in adenocarcinomas of the esophagogastric junction. J Cancer Res Clin Oncol. 1996;122(3):186–188. doi: 10.1007/BF01366961. [DOI] [PubMed] [Google Scholar]
  26. Sasaki K., Hashimoto T., Kawachino K., Takahashi M. Intratumoral regional differences in DNA ploidy of gastrointestinal carcinomas. Cancer. 1988 Dec 15;62(12):2569–2575. doi: 10.1002/1097-0142(19881215)62:12<2569::aid-cncr2820621220>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  27. Sasaki K., Takahashi M., Hashimoto T., Kawachnino K. Flow cytometric DNA measurement of gastric cancers. Clinico-pathological implication of DNA ploidy. Pathol Res Pract. 1989 Jun;184(6):561–566. doi: 10.1016/S0344-0338(89)80160-8. [DOI] [PubMed] [Google Scholar]
  28. Shankey T. V., Rabinovitch P. S., Bagwell B., Bauer K. D., Duque R. E., Hedley D. W., Mayall B. H., Wheeless L., Cox C. Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry. 1993;14(5):472–477. doi: 10.1002/cyto.990140503. [DOI] [PubMed] [Google Scholar]
  29. Sigurdsson H., Baldetorp B., Borg A., Dalberg M., Fernö M., Killander D., Olsson H. Indicators of prognosis in node-negative breast cancer. N Engl J Med. 1990 Apr 12;322(15):1045–1053. doi: 10.1056/NEJM199004123221505. [DOI] [PubMed] [Google Scholar]
  30. Tosi P., Leoncini L., Cintorino M., Vindigni C., Minacci C., Nuti S., Pinto E., de Stefano A., Cevenini G. Flow cytometric analysis of DNA ploidy pattern from deparaffinized formalin-fixed gastric cancer tissue. Int J Cancer. 1988 Dec 15;42(6):868–871. doi: 10.1002/ijc.2910420613. [DOI] [PubMed] [Google Scholar]
  31. Victorzon M., Roberts P. J., Haglund C., von Boguslawsky K., Nordling S. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology. 1996 May-Jun;53(3):182–191. doi: 10.1159/000227558. [DOI] [PubMed] [Google Scholar]
  32. Vindeløv L. L., Christensen I. J., Keiding N., Spang-Thomsen M., Nissen N. I. Long-term storage of samples for flow cytometric DNA analysis. Cytometry. 1983 Mar;3(5):317–322. doi: 10.1002/cyto.990030502. [DOI] [PubMed] [Google Scholar]
  33. Vindeløv L. L., Christensen I. J., Nissen N. I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983 Mar;3(5):323–327. doi: 10.1002/cyto.990030503. [DOI] [PubMed] [Google Scholar]
  34. Wyatt J. I., Quirke P., Ward D. C., Clayden A. D., Dixon M. F., Johnston D., Bird C. C. Comparison of histopathological and flow cytometric parameters in prediction of prognosis in gastric cancer. J Pathol. 1989 Jul;158(3):195–201. doi: 10.1002/path.1711580305. [DOI] [PubMed] [Google Scholar]
  35. Yonemura Y., Fonseca L., Tsugawa K., Ninomiya I., Matsumoto H., Sugiyama K., Ohoyama S., Fushida S., Kimura H., Miyazaki I. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer. Oncology. 1994 May-Jun;51(3):251–257. doi: 10.1159/000227344. [DOI] [PubMed] [Google Scholar]
  36. Yonemura Y., Ooyama S., Sugiyama K., Kamata T., De Aretxabala X., Kimura H., Kosaka T., Yamaguchi A., Miwa K., Miyazaki I. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma. Cancer Res. 1990 Feb 1;50(3):509–514. [PubMed] [Google Scholar]
  37. de Aretxabala X., Yonemura Y., Sugiyama K., Hirose N., Kumaki T., Fushida S., Miwa K., Miyazaki I. Gastric cancer heterogeneity. Cancer. 1989 Feb 15;63(4):791–798. doi: 10.1002/1097-0142(19890215)63:4<791::aid-cncr2820630431>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES